Stay updated on Venetoclax Plus Inotuzumab in B-ALL Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Plus Inotuzumab in B-ALL Clinical Trial page.

Latest updates to the Venetoclax Plus Inotuzumab in B-ALL Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe history now shows a new Revision: v3.3.3 entry. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 have been removed from the page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history shows an addition of v3.3.2 and removal of v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision v3.3.1 was added to the study record history, while revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the page-wide government funding status banner; core trial information and history data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check61 days agoChange DetectedA new history version dated 2025-01-21 is added, updating the Study Status in the Record History. The rest of the version history remains unchanged.SummaryDifference0.1%

- Check90 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference13%

Stay in the know with updates to Venetoclax Plus Inotuzumab in B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Plus Inotuzumab in B-ALL Clinical Trial page.